TUSSICAPS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tussicaps, and when can generic versions of Tussicaps launch?
Tussicaps is a drug marketed by Ecr Pharma and is included in one NDA.
The generic ingredient in TUSSICAPS is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TUSSICAPS?
- What are the global sales for TUSSICAPS?
- What is Average Wholesale Price for TUSSICAPS?
Summary for TUSSICAPS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 21 |
| DailyMed Link: | TUSSICAPS at DailyMed |
US Patents and Regulatory Information for TUSSICAPS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ecr Pharma | TUSSICAPS | chlorpheniramine polistirex; hydrocodone polistirex | CAPSULE, EXTENDED RELEASE;ORAL | 077273-002 | Sep 24, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ecr Pharma | TUSSICAPS | chlorpheniramine polistirex; hydrocodone polistirex | CAPSULE, EXTENDED RELEASE;ORAL | 077273-001 | Sep 24, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
